IMUC
ImmunoCellular Therapeutics, Ltd.
IMUC
IMUC
Delisted
IMUC was delisted on the 16th of October, 2018.
36 hedge funds and large institutions have $4.66M invested in ImmunoCellular Therapeutics, Ltd. in 2014 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 7 increasing their positions, 11 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
36% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 11
Holders
36
Holding in Top 10
–
Calls
$705K
Puts
$678K
Top Buyers
| 1 | +$691K | |
| 2 | +$224K | |
| 3 | +$125K | |
| 4 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$24.9K |
| 5 |
JMPWA
JP Morgan Private Wealth Advisors
San Francisco,
California
|
+$24K |
Top Sellers
| 1 | -$148K | |
| 2 | -$136K | |
| 3 | -$116K | |
| 4 |
DS
DRW Securities
Chicago,
Illinois
|
-$111K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$96.5K |